Signaling through the JAK/STAT pathway, recent advances and future challenges - PubMed

Review

Signaling through the JAK/STAT pathway, recent advances and future challenges

T Kisseleva et al. Gene. 2002.

Abstract

Investigation into the mechanism of cytokine signaling led to the discovery of the JAK/STAT pathway. Following the binding of cytokines to their cognate receptor, signal transducers and activators of transcription (STATs) are activated by members of the janus activated kinase (JAK) family of tyrosine kinases. Once activated, they dimerize and translocate to the nucleus and modulate the expression of target genes. During the past several years significant progress has been made in the characterization of the JAK/STAT signaling cascade, including the identification of multiple STATs and regulatory proteins. Seven STATs have been identified in mammals. The vital role these STATs play in the biological response to cytokines has been demonstrated through the generation of murine 'knockout' models. These mice will be invaluable in carefully elucidating the role STATs play in regulating the host response to various stresses. Similarly, the solution of the crystal structure of two STATs has and will continue to facilitate our understanding of how STATs function. This review will highlight these exciting developments in JAK/STAT signaling.

Similar articles

• The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus.

  Heim MH. Heim MH. J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):75-120. doi: 10.3109/10799899909036638. J Recept Signal Transduct Res. 1999. PMID: 10071751 Review.

• The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs).

  Pellegrini S, Dusanter-Fourt I. Pellegrini S, et al. Eur J Biochem. 1997 Sep 15;248(3):615-33. doi: 10.1111/j.1432-1033.1997.00615.x. Eur J Biochem. 1997. PMID: 9342212 Review.

• IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.

  Reddy EP, Korapati A, Chaturvedi P, Rane S. Reddy EP, et al. Oncogene. 2000 May 15;19(21):2532-47. doi: 10.1038/sj.onc.1203594. Oncogene. 2000. PMID: 10851052 Review.

• Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.

  Podewski EK, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, Wollert KC, Drexler H. Podewski EK, et al. Circulation. 2003 Feb 18;107(6):798-802. doi: 10.1161/01.cir.0000057545.82749.ff. Circulation. 2003. PMID: 12591746

• Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

  Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L. Heinrich PC, et al. Biochem J. 1998 Sep 1;334 ( Pt 2)(Pt 2):297-314. doi: 10.1042/bj3340297. Biochem J. 1998. PMID: 9716487 Free PMC article. Review.

Cited by

• Low JAK2 V617F Allele Burden in Ph-Negative Chronic Myeloproliferative Neoplasms Is Associated with Additional CALR or MPL Gene Mutations.

  Makarik TV, Abdullaev AO, Nikulina EE, Treglazova SA, Stepanova EE, Subortseva IN, Kovrigina AM, Melikyan AL, Kulikov SM, Sudarikov AB. Makarik TV, et al. Genes (Basel). 2021 Apr 12;12(4):559. doi: 10.3390/genes12040559. Genes (Basel). 2021. PMID: 33921387 Free PMC article.

• Multiomic Analysis of Methylation and Transcriptome Reveals a Novel Signature in Esophageal Cancer.

  Jin YQ, Miao DL. Jin YQ, et al. Dose Response. 2020 Jul 15;18(3):1559325820942075. doi: 10.1177/1559325820942075. eCollection 2020 Jul-Sep. Dose Response. 2020. PMID: 32728353 Free PMC article.

• Long non-coding RNA LNC_000641 regulates pseudorabies virus replication.

  Fang L, Gao Y, Liu X, Bai J, Jiang P, Wang X. Fang L, et al. Vet Res. 2021 Mar 25;52(1):52. doi: 10.1186/s13567-021-00922-0. Vet Res. 2021. PMID: 33766129 Free PMC article.

• Human β-defensin 3 induces STAT1 phosphorylation, tyrosine phosphatase activity, and cytokine synthesis in T cells.

  Meisch JP, Vogel RM, Schlatzer DM, Li X, Chance MR, Levine AD. Meisch JP, et al. J Leukoc Biol. 2013 Sep;94(3):459-71. doi: 10.1189/jlb.0612300. Epub 2013 Jun 26. J Leukoc Biol. 2013. PMID: 23804808 Free PMC article.

• Initial experience of tofacitinib for treating refractory moderate-to-severe ulcerative colitis.

  Nakamura M, Yamamura T, Maeda K, Sawada T, Mizutani Y, Ishikawa E, Ishikawa T, Kakushima N, Furukawa K, Ohno E, Kawashima H, Honda T, Ishigami M, Fujishiro M. Nakamura M, et al. Nagoya J Med Sci. 2022 Feb;84(1):169-179. doi: 10.18999/nagjms.84.1.169. Nagoya J Med Sci. 2022. PMID: 35392018 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • FlyBase

• Miscellaneous

  • NCI CPTAC Assay Portal